Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model

Philippou Y. et al, (2020), British Journal of Cancer

The clinical and molecular significance associated with STING signaling in estrogen receptor-positive early breast cancer

Parkes EE. et al, (2020)

Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial

Sharma P. et al, (2019), Journal of Clinical Oncology, 37, 3484 - 3492

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study

McCain RS. et al, (2019), Cancer Causes & Control, 31, 1 - 11

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.

Turkington RC. et al, (2019), Gut, 68, 1918 - 1927

Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application.

Lightbody G. et al, (2019), Brief Bioinform, 20, 1795 - 1811

DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy.

Gilmore E. et al, (2019), J Oncol, 2019

Topoisomerase II inhibitors induce cGAS-STING dependent inflammation resulting in cytokine induction and immune checkpoint activation

Wilkinson RDA. et al, (2019)

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer

Humphries MP. et al, (2018), Journal of Oncology, 2018, 1 - 14

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

Parkes EE. et al, (2016), Journal of the National Cancer Institute, 109, djw199 - djw199

Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer.

Parkes EE. and Kennedy RD., (2016), Oncologist, 21, 586 - 593

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.

Buckley NE. et al, (2016), Oncotarget, 7, 19884 - 19896

Turning the concept of synthetic lethality on its head

Parkes EE. and Kennedy RD., (2016), TRANSLATIONAL CANCER RESEARCH, 5, S1145 - S1148

Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction.

Turkington RC. et al, (2015), J Clin Oncol, 33